###begin article-title 0
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 44 50 <span type="species:ncbi:10090">murine</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 119 125 <span type="species:ncbi:10090">murine</span>
The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 124 126 124 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 423 424 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 596 598 596 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3</italic>
###xml 745 749 745 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 749 751 749 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 929 931 929 931 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 949 951 949 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1017 1018 1017 1018 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1028 1029 1028 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1043 1047 1043 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 1047 1048 1047 1048 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1109 1111 1109 1111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1157 1159 1157 1159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1277 1278 1277 1278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1340 1344 1340 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 1344 1346 1344 1346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1398 1403 1398 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3 </italic>
###xml 1580 1582 1580 1582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 37 43 <span type="species:ncbi:10090">murine</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 294 300 <span type="species:ncbi:10090">murine</span>
###xml 522 528 <span type="species:ncbi:10090">murine</span>
###xml 533 538 <span type="species:ncbi:9606">human</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
###xml 1185 1189 <span type="species:ncbi:10090">mice</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
###xml 1323 1329 <span type="species:ncbi:10090">murine</span>
###xml 1334 1339 <span type="species:ncbi:9606">human</span>
Systemic lupus erythematosus and its murine equivalent, modelled in the New Zealand Black and New Zealand White (NZB x NZW)F1 hybrid strain, are polygenic inflammatory diseases, probably reflecting an autoimmune response to debris from cells undergoing programmed cell death. Several human and murine loci contributing to disease have been defined. The present study asks whether the proinflammatory purinergic receptor P2X7, an initiator of a form of programmed cell death known as aponecrosis, is a candidate product of murine and human lupus susceptibility loci. One such locus in (NZB x NZW)F1 mice is lbw3, which is situated at the distal end of NZW chromosome 5. We first assess whether NZB mice and NZW mice carry distinct alleles of the P2RX7 gene as expressed by common laboratory strains, which differ in sensitivity to ATP stimulation. We then compare the responses of NZB lymphocytes, NZW lymphocytes and (NZB x NZW)F1 lymphocytes to P2X7 stimulation. NZB and NZW parental strains express the distinct P2X7-L and P2X7-P alleles of P2RX7, respectively, while lymphocytes from these and (NZB x NZW)F1 mice differ markedly in their responses to P2X7 receptor stimulation. NZB mice and NZW mice express functionally distinct alleles of the proinflammatory receptor, P2X7. We show that current mapping suggests that murine and human P2RX7 receptor genes lie within lupus susceptibility loci lbw3 and SLEB4, and we argue that these encode a product with the functional characteristics consistent with a role in lupus. Furthermore, we argue that aponecrosis as induced by P2X7 is a cell death mechanism with characteristics that potentially have particular relevance to disease pathogenesis.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 382 384 382 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 532 534 532 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 617 619 617 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 697 701 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3</italic>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 956 961 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3 </italic>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 311 317 <span type="species:ncbi:10090">murine</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
###xml 493 498 <span type="species:ncbi:9606">human</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 873 879 <span type="species:ncbi:10090">murine</span>
Systemic lupus erythematosus (SLE) is a polygenic disease, although the genes contributing towards the disease are unknown. Several human susceptibility loci have been identified, with eight of the strongest candidates mapping to 1q23, 1q25-31, 1q41-42, 2q35-37, 4p16-15.2, 6p11-21, 12q24 and 16q12 [1]. Of the murine models, the New Zealand Black and New Zealand White (NZB x NZW)F1 hybrid strain is widely studied due to its similarity to human disease and its female preponderance. As with human SLE, the disorder of (NZB x NZW)F1 mice is polygenic with a contribution from both parents. In a study of (NZB x NZW)F2 mice, eight susceptibility loci were identified [2]. In the case of the locus lbw3, at the distal region of chromosome 5, homozygosity for the NZW-derived locus was associated with increased mortality at 12 months. Although originally mapped to 88 cM on murine chromosome 5 [2], more recent data locate the microsatellite used to define lbw3 at 81 cM (discussed later).
###end p 4
###begin p 5
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3 </italic>
###xml 279 281 279 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 442 444 442 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 635 636 635 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 753 754 750 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 182 188 <span type="species:ncbi:10090">murine</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
We have studied the properties of the proinflammatory purinergic receptor P2X7, encoded by a gene within the human SLE locus SLEB4 [3] at 12q24 (Ensembl Genome Browser: ) and by the murine lbw3 region (Ensembl Genome Browser: ), and discuss its potential role in disease. The P2X7 receptor belongs to a family of ion channels gated by extracellular ATP, but unlike other P2X receptors it is largely restricted to haematopoietic cells. The P2X7 receptor has been proposed to play a role in a variety of immune functions including the secretion of leaderless cytokines and the shedding of the lymphocyte homing receptor CD62L [4]. As P2X7-deficient mice exhibit resistance to antibody-induced arthritis and impaired CD62L shedding and IL-1beta secretion [5], stimulation of this receptor is proinflammatory - suggesting a potential role in autoimmune disease.
###end p 5
###begin p 6
###xml 218 220 218 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 397 399 397 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1038 1040 1038 1040 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1326 1327 1326 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1358 1360 1358 1360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
In this respect, SLE is of particular interest. Not only is SLE an inflammatory disorder, but it probably reflects, at least in part, an immune response to debris of cells undergoing programmed cell death (PCD). As P2X7 stimulation is proinflammatory and induces PCD, functional polymorphisms in this gene would be predicted to affect lupus susceptibility. Moreover, PCD stimulated through the P2X7 receptor belongs to a category that bears many of the hallmarks of 'classic' caspase-dependent apoptosis, but also to other categories such as cytoplasmic vacuolization more often associated with necrosis. Such cell death has sometimes been termed 'aponecrosis' [6]. Whereas removal of 'classic' apoptotic cells is believed to be immunologically silent, necrotic cell debris is proinflammatory [7]. The effect of intermediate forms of PCD such as aponecrosis, for which clearance mechanisms have not been defined, is unknown, yet such material potentially plays a significant role in the pathogenesis of SLE (discussed later). Finally, P2X7 stimulation results in rapid translocation of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane, which is reversible if stimulation is brief (and thus independent of cell death). As PS and associated proteins are major targets of autoantibodies in SLE [8], cells stimulated via the P2X7 receptor may be a significant source of autoantigen in this disease.
###end p 6
###begin p 7
###xml 65 67 65 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 229 230 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 432 434 432 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 611 612 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 686 688 686 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 755 757 755 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 805 806 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1009 1011 1009 1011 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1069 1074 1069 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3 </italic>
###xml 1094 1098 1094 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 1098 1100 1098 1100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
###xml 1062 1068 <span type="species:ncbi:10090">murine</span>
###xml 1088 1093 <span type="species:ncbi:9606">human</span>
###xml 1196 1201 <span type="species:ncbi:9606">human</span>
An allelic variation (P451L) of the cytoplasmic domain of the P2X7 receptor in commonly used mouse strains is associated with significant differences in its sensitivity to the ATP ligand [9]. These allelic forms with proline (P2X7-P) and leucine (P2X7-L) at position 451 confer high sensitivity and low sensitivity to stimulation by ATP, respectively. While the NZW strain has been shown to express the more responsive allele of P2X7 (P2X-P) [9], that expressed by the NZB strain is unknown. We show in the present article that NZB mice and NZW mice express different alleles of the proinflammatory receptor P2X7, and furthermore that NZW lymphocytes are markedly more responsive to P2X7 stimulation than those from NZB mice. Lymphocytes from (NZB x NZW)F1 mice exhibited intermediate sensitivities to P2X7-induced PS translocation and to PCD, but were as sensitive to induction of CD62L shedding as those from NZW mice, indicating a comparatively complex phenotypic penetration. The results indicate that P2X7 is a strong candidate for being the product of the murine lbw3 locus. As the human P2RX7 gene maps close to SLEB4, we hypothesize that similar polymorphisms may also contribute towards human disease.
###end p 7
###begin title 8
Methods
###end title 8
###begin title 9
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 9
###begin p 10
###xml 5 9 <span type="species:ncbi:10090">mice</span>
Male mice were purchased from Harlan-Olac (Bicester, UK) and used at between 8 and 14 weeks. Institute guidelines for care of laboratory animals were followed. All studies received ethical review approval.
###end p 10
###begin title 11
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
P2X7 PCRs
###end title 11
###begin p 12
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
PCR amplification of the NZB mouse genomic sequence encompassing the T1352C polymorphism [9] was performed using the forward and reverse primers CCTGTCTAGGCTGTCCCTAT and GCTTATGGAAGAGCTTGGAG for 30 cycles. PCR products were cloned using the TOPO TA cloning system (Invitrogen, Paisley, UK). Forty-three independent clones were sequenced using an ABI PRISM Big Dye terminator ready reaction kit (Applied Biosystems, Warrington, UK) and were analysed on a 3700 DNA Analyser (Applied Biosystems). Nucleotide and amino acid substitutions were numbered using the cDNA sequence accession number NM-011027.
###end p 12
###begin title 13
Reagents
###end title 13
###begin p 14
Matrix metalloproteinase inhibitor III was from Calbiochem (Nottingham, UK). Other reagents were from Sigma (Poole, UK), unless stated. Diluents had no effect in any assay used.
###end p 14
###begin title 15
Flow cytometry
###end title 15
###begin p 16
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">APC</sup>
###xml 107 115 107 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CYCHROME</sup>
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">PE</sup>
###xml 127 130 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">APC</sup>
###xml 135 143 135 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CYCHROME</sup>
###xml 148 150 148 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">PE</sup>
###xml 155 160 155 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC </sup>
###xml 169 174 169 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC </sup>
###xml 300 305 300 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC </sup>
###xml 317 321 317 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CY5 </sup>
###xml 702 703 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
Mesenteric lymphocyte cells (107/ml) in phenol red-free DMEM were stained with a combination of CD4APC, CD4CYCHROME, CD4PE, CD8APC, CD8CYCHROME, CD8PE, CD8FITC and CD62LFITC antibodies (Becton Dickinson, Oxford, UK) as indicated, washed and resuspended in DMEM. Cells were equilibrated with annexin VFITC or annexin VCY5 (Becton Dickinson) to assess cell surface PS exposure, or with propidium iodide for 4 min to assess cell death, and were analysed by flow cytometry on a FACScalibur machine using CellQuest (Becton Dickinson) or Flowjo (Tree Star, Ashland, OR, USA) software. Baseline fluorescence was established for approximately 1 min prior to addition of 150 muM (unless otherwise stated) 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP). Cells were monitored for PS exposure or CD62L shedding continuously in real time for up to 9 min or were monitored for uptake of propidium iodide, as indicated. All results are representative of at least three independent experiments.
###end p 16
###begin title 17
IL-1beta secretion
###end title 17
###begin p 18
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 830 832 805 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 672 677 <span type="species:ncbi:10090">mouse</span>
Spleens from NZW mice and NZB mice were disaggregated and erythrocytes were lysed (Puregene RBC lysis solution; Gentra Ltd, Minneapolis, MN, USA). Splenocytes (5 x 106/ml) were then resuspended in DMEM supplemented with 10% FCS (Helena Biosciences, Sunderland, UK), and were stimulated with 2 mug/ml lipopolysaccharide. After 6 hours at 37degreesC the medium was removed and replaced with DMEM. Cells were then incubated at 37degreesC for 30 min with BzATP added as indicated. The supernatant was then collected and the cells and particulate matter were removed by centrifugation. Supernatants were then frozen at -20degreesC. IL-1beta was quantified by ELISA (Quantikine mouse IL-1beta kit; R&D Systems, Minneapolis, MN, USA) in accordance with the manufacturer's instructions. Statistical significance was measured by Student's t test.
###end p 18
###begin title 19
Results
###end title 19
###begin title 20
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 96 98 96 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Real-time comparison of P2X7-stimulated PS translocation and CD62L shedding by NZW, (NZB x NZW)F1 and NZB lymphocytes
###end title 20
###begin p 21
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 80 82 80 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 285 287 285 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 487 489 487 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 552 554 552 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
We initially confirmed that NZW mice are homozygous for the P2X-P allele of P2RX7 [9] associated with high sensitivity to stimulation, and we showed that NZB mice are homozygous for the low sensitivity allele P2X-L (data not shown). These forms differ at a single amino acid (451). P2X7 activation, stimulated by BzATP (Fig. 1), results in rapid externalization of PS and shedding of CD62L. We therefore developed real-time flow cytometric assays to directly compare the responses to P2X7 simulation of NZB lymphocytes, NZW lymphocytes and (NZB x NZW)F1 lymphocytes.
###end p 21
###begin title 22
PS translocation
###end title 22
###begin p 23
###xml 326 328 326 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 414 422 414 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CYCHROME</sup>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">PE </sup>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink">APC</sup>
###xml 503 508 503 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC </sup>
###xml 631 632 631 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 853 855 853 855 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 926 928 926 928 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1034 1036 1034 1036 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1100 1101 1100 1101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1162 1164 1162 1164 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1231 1232 1231 1232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1240 1242 1240 1242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 701 706 <span type="species:ncbi:10090">mouse</span>
###xml 1126 1130 <span type="species:ncbi:10090">mice</span>
###xml 1249 1253 <span type="species:ncbi:10090">mice</span>
PS is largely confined to the inner leaflet of the plasma membrane in healthy cells. Loss of lipid asymmetry, as evidenced by surface exposure of PS occurring prior to membrane breakdown, is generally assumed to be a marker of PCD. To enable the direct comparison of responses of cells from NZB mice, NZW mice and (NZB x NZW)F1 mice in a single tube, lymphocytes from these three strains were stained with anti-CD4CYCHROME, anti-CD4PE and anti-CD4APC, respectively, mixed and equilibrated with annexin VFITC (to detect exposed PS). Labelled cells could thus subsequently be distinguished by flow cytometric gating. The rates of P2X7-stimulated PS exposure by lymphocyte subsets derived from the three mouse strains were directly compared by real-time flow cytometry (Fig. 1). Baseline fluorescence was established, and cells were stimulated with the P2X7 agonist BzATP at the time indicated. The order of responsiveness to P2X7 stimulation, as evidenced by the percentage of cells translocating PS, was consistently NZW > (NZB x NZW)F1 > NZB. Therefore, consistent with the greater sensitivity of P2X7-P, lymphocytes from NZW mice show greater sensitivity to P2X7 stimulation, and show co-dominance with the NZB-derived allele (P2X7-L) in F1 hybrid mice.
###end p 23
###begin title 24
CD62L shedding
###end title 24
###begin p 25
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 130 132 130 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 197 199 197 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 321 326 321 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC </sup>
###xml 404 405 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 518 519 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 623 624 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 683 685 683 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 771 773 771 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 868 870 868 870 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1090 1092 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
Shedding of CD62L from T cells is a key event in lymphocyte migration to inflammatory sites [10] and is known to be induced by P2X7 stimulation. Lymphocytes from NZB mice, NZW mice and (NZB x NZW)F1 mice were differentially stained as already stated but were labelled with FITC-conjugated anti-CD62L in place of annexin VFITC to allow direct comparison of the rate of CD62L shedding in a single tube. P2X7-stimulated CD62L shedding was apparent as a decrease in fluorescence in the FL-1 channel. While the rates of P2X7-stimulated CD62L shedding were high and low in NZW lymphocytes and NZB lymphocytes, respectively (Fig. 2), interestingly the rate of CD62L shedding by (NZB x NZW)F1 lymphocytes was indistinguishable from that by NZW cells. The high NZW response of P2X7 thus appears dominant with respect to CD62L shedding, indicating that factors downstream of P2X7 stimulation contribute to this phenotype. That loss of CD62L reflects shedding and not decreased cell surface expression through other mechanisms is evidenced by its blockade by an inhibitor of matrix metalloproteinase [11] (Fig. 2c).
###end p 25
###begin title 26
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
P2X7-induced secretion of IL-1beta
###end title 26
###begin p 27
###xml 22 24 22 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 153 154 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 155 157 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 226 227 223 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 236 237 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 307 316 301 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 388 390 382 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 432 433 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 658 660 648 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 949 951 936 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 960 968 947 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
Stimulation of the P2X7 receptor on lipopolysaccharide-stimulated monocytes and macrophages promotes secretion of the proinflammatory cytokine IL-1beta [5,12], which may therefore be expected to differ between mice bearing P2X7-L or P2X7-P receptors. Indeed IL-1beta secretion by NZW splenocytes stimulated in vitro with lipopolysaccharide and BzATP exceeded that by cells from NZB mice (P < 0.05 at 50, 100 and 150 muM BzATP; Fig. 3). Elevated IL-1beta secretion by NZW splenocytes was apparent even in the absence of BzATP (although slightly below statistical significance), suggesting that inadvertent stimulation of the high (but not low) sensitivity P2X7 receptor may have occurred through cell death and the consequent release of ATP during cell preparation (spleen disaggregation and erythrocyte lysis). In one NZW splenocyte preparation exhibiting particularly high IL-1beta secretion, cells were refractory to further stimulation of the P2X7 receptor in vitro.
###end p 27
###begin title 28
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
P2X7-induced PCD of NZW and NZB lymphocytes
###end title 28
###begin p 29
###xml 142 144 142 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 334 336 334 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 465 467 465 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 659 661 659 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 686 688 686 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 803 805 803 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 908 912 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 912 914 912 914 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
Several lines of evidence indicate that lupus reflects an autoimmune response to debris from cells undergoing PCD. Although stimulation of P2X7 results in rapid PS translocation, the effects are reversible if exposure to the agonist is brief [4]. Only prolonged treatment with agonist results in PCD. Translocation of PS following P2X7 activation cannot therefore be used as a direct measure of irreversible commitment to PCD. To measure PCD following prolonged P2X7 stimulation, we therefore compared the rate of terminal membrane breakdown (indicated by propidium iodide uptake) following BzATP treatment of NZW lymphocytes, NZB lymphocytes and (NZB x NZW)F1 lymphocytes (Fig. 4). P2X7 stimulation resulted in significant PCD in all populations tested, with the order of sensitivity NZW > (NZB x NZW)F1 > NZB, consistent with the high responder status of the NZW cells and the dominance of the NZW-derived P2RX7 allele in this response.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 53 55 53 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 65 66 65 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 121 122 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 147 149 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 196 198 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 199 201 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 211 213 208 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 343 345 340 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 534 535 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 334 339 <span type="species:ncbi:9606">human</span>
Stimulation of the proinflammatory haematopoietic P2X7 receptor [5] results in IL-1beta secretion, in high rates of PCD [4] and in CD62L shedding [13], each of which is associated with human SLE [14-16]. The P2X7 receptor therefore has the characteristics of a candidate lupus susceptibility gene product. Moreover, the gene encoding human P2X7 is located within a region (12q24; Ensembl Genome Browser: ) recently identified and confirmed in Hispanic and European-American Families as a lupus susceptibility locus, designated SLEB4 [3].
###end p 31
###begin p 32
###xml 51 53 51 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 261 263 261 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 358 360 358 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 397 399 397 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3 </italic>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 652 661 652 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D5Mit101 </italic>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3 </italic>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 785 789 785 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 789 791 789 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 963 972 963 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D5Mit118 </italic>
###xml 992 996 992 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 996 998 996 998 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 1211 1212 1211 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 386 392 <span type="species:ncbi:10090">murine</span>
###xml 894 899 <span type="species:ncbi:10090">Mouse</span>
###xml 1048 1053 <span type="species:ncbi:10090">Mouse</span>
A polymorphism in the cytoplasmic domain of the P2X7 receptor of common mouse strains is associated with differential responsiveness [9]. While most strains, including NZW mice [9], possess proline in amino acid position 451, we showed that NZB mice express P2X7 with lysine at this position and that the variant confers markedly decreased sensitivity to P2X7 stimulation. Notably, the murine P2RX7 gene is encoded by a gene on chromosome 5 within a region designated lbw3 due to the identification of a NZW-derived susceptibility locus conferring increased mortality at 12 months [2]. While susceptibility regions are broad, the microsatellite marker D5Mit101 (defining lbw3 [2]) was in the original study mapped to 88 cM on chromosome 5, which may have discouraged identification of P2RX7 as a candidate susceptibility gene. Current mapping data, however, show this marker located at 81 cM - Mouse Genome Informatics  and Ensembl Genome Browser . As the marker D5Mit118 that is adjacent to P2RX7 is located at 67 cM - Ensembl Genome Browser  and Mouse Genome Informatics  - the two are approximately 14 cM (or 19 Mb) apart (120 Mb versus 139 Mb), easily within the 20 cM distance used by Kono and colleagues [2] to define coverage by markers in their study.
###end p 32
###begin p 33
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 73 75 73 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3</italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 334 335 334 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
Although gene polymorphisms may have unpredicted effects, other than P2RX7 there appear to be few candidate susceptibility genes (based on lymphoid expression and protein activity) in the region described by lbw3. However, other candidates might include those encoding: lnk, an adaptor protein in T-cell signalling (65.0 cM) [17]; P2X4, a purinergic receptor (65.0 cM) whose activity is assumed primarily to be neuronal, but which is also expressed (at least at the level of mRNA) in lymphocytes [18]; shp2, a tyrosine phosphatase [19] (~66 cM [118.6 Mb]); and FLT3 (CD135, 82.0 cM), a tyrosine kinase expressed in haemaotopoietic cells [20]. None of these has been reported to be polymorphic between NZB mice and NZW mice.
###end p 33
###begin p 34
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 388 390 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 950 956 950 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 1227 1228 1227 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 332 337 <span type="species:ncbi:9606">human</span>
It is widely thought that lupus reflects an autoimmune response to cells undergoing PCD. Aberrant responses to such debris may reflect qualitative or quantitative abnormalities; for example, if its handling is defective and/or following exposure to increased levels of 'apoptotic' material. Both have been reported to contribute to human SLE [15,16]. That prolonged stimulation of the P2X7 receptor induces PCD is therefore of particular note. However, multiple pathways of PCD exist. While 'apoptosis' and 'PCD' are frequently used as synonyms, 'apoptosis' is often used to imply caspase-dependent cell death. Nevertheless, caspase involvement is not a good indicator of the physiologic importance, or 'programming', of a cell death pathway, and consequently classic 'apoptosis' may describe one end of a continuum of active PCD mechanisms [21]. Hence, in principle, a defect in one of many PCD pathways, rather than increased susceptibility to PCD per se, may be sufficient to increased the burden of cellular debris and hence the susceptibility to lupus. Indeed, that SLE may reflect an autoimmune response to debris from 'apoptotic' cells, despite clearance of such material being thought generally immunologically silent [7], has been a conundrum.
###end p 34
###begin p 35
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 548 549 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 953 954 953 954 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 972 974 972 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
To reconcile these findings it has been suggested that, in SLE, mechanisms for removing apoptotic debris are overloaded, with remaining cells undergoing secondary necrosis, and/or that apoptotic cells have some immunostimulatory properties [7]. We suggest the additional possibility that different forms of PCD may give rise to debris with different degrees of immunogenicity. It is therefore necessary to dissect distinct PCD pathways to assess the potential effects that defects have on the disease process. It is attractive to speculate that P2X7-induced aponecrotic debris, perhaps due to the catastrophic nature of its generation or the apparent differences in cell dismantling, may be more necrotic than apoptotic in character and thus be immunostimulatory. Such material may either promote responses to surrounding 'apoptotic' cells and/or directly stimulate autoimmune responses to itself (if lupus autoantigens are appropriately packaged in P2X7-induced PCD). P2X7 receptor-induced PCD is therefore potentially a source of lupus autoantigens or may represent a catastrophic form of cell death that overwhelms the host's ability to clear such material.
###end p 35
###begin p 36
###xml 57 59 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 358 360 358 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 480 482 477 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 681 682 678 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 778 780 775 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 894 895 891 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
We therefore suggest the following involvement of the P2X7 receptor in SLE. ATP exists at very high concentrations in normal cells (5-10 mM), and is released upon cell death before its rapid breakdown by ATPases. Consequently, extracellular concentrations of ATP, although normally low, are transiently increased at sites of tissue damage. Stimulation of P2X7 occurs at sufficient concentrations of ATP, resulting in secretion of IL-1beta and in CD62L shedding within minutes. P2X7 stimulation thus acts to promote the inflammatory response. The resulting lymphoid infiltration leads to additional lymphocyte-mediated cell death, and to consequent ATP release, exacerbating the P2X7-driven inflammatory cycle. Indeed, given sufficient tissue damage, prolonged stimulation of P2X7 itself induces PCD, further adding to the cycle of ATP release and destruction. Release of autoantigens within P2X7-stimulated aponecrotic debris may also contribute to a breakdown in self-tolerance and initiation of autoimmunity.
###end p 36
###begin p 37
###xml 286 288 286 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 388 390 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 551 552 551 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 542 547 <span type="species:ncbi:9606">human</span>
While one must make the proviso that little is known at the moment about the level of ATP released at sites of tissue damage, its rate of decay and how these may vary between pathological conditions including SLE, we suggest it is reasonable to hypothesize that polymorphisms within P2X7 can influence the pathogenesis of lupus. Importantly, there are a number of polymorphisms within P2X7 that affect its activity. The Ile-568 to Asn [22], Arg307 to Gln [23], and Glu496 to Ala [24] polymorphisms therefore all result in reduced function of human P2X7, and might each be hypothesized to result in decreased severity of SLE.
###end p 37
###begin title 38
Conclusions
###end title 38
###begin p 39
###xml 54 56 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 137 138 137 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 342 344 342 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lbw3 </italic>
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 592 594 592 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 654 656 654 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 825 827 825 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 510 515 <span type="species:ncbi:9606">human</span>
###xml 617 622 <span type="species:ncbi:9606">human</span>
In summary, we have shown that polymorphism of the P2X7 receptor between NZW and NZB strains is associated with marked differences in P2X7-stimulated proinflammatory responses, consistent with high responsiveness and low responsiveness previously reported for the two alleles. We also show that current genetic mapping indicates that the P2RX7 gene is located within the region defined as lbw3 and is a therefore a strong candidate for being the product of this lupus susceptibility locus. Furthermore, as the human gene maps very close to SLEB4, we hypothesize that polymorphisms within P2RX7 may also contribute to human disease. Stimulation of the P2X7 receptor is proinflammatory and induces a form of cell death known as aponecrosis, which exhibits several characteristics of apoptosis. We therefore suggest that the P2X7 receptor and gene have the functional and positional characteristics suggestive of a role in the pathogenesis in SLE, and that the potential of the cell death mechanism aponecrosis to contribute to disease warrants study.
###end p 39
###begin title 40
Abbreviations
###end title 40
###begin p 41
###xml 14 15 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 161 165 <span type="species:ncbi:9913">calf</span>
BzATP = 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate; DMEM = Dulbecco's modified Eagle's medium; ELISA = enzyme-linked immunosorbent assay; FCS = foetal calf serum; FITC = fluorescein isothiocyanate; IL = interleukin; NZB = New Zealand Black; NZW = New Zealand White; PCD = programmed cell death; PCR = polymerase chain reaction; PS = phosphatidylserine; SLE = systemic lupus erythematosus.
###end p 41
###begin title 42
Competing interests
###end title 42
###begin p 43
The author(s) declare there are no competing interests.
###end p 43
###begin title 44
Authors' contributions
###end title 44
###begin p 45
###xml 189 193 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2RX</italic>
###xml 193 195 190 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
JIE conceived the study, carried out the flow cytometric and IL-1beta secretion experiments, and wrote the first draft of the manuscript. JHM designed allele-specific primers and typed the P2RX7 genes of NZB mice and NZW mice, and contributed to drafting of the manuscript. CFH contributed to the design of experiments and drafting of the manuscript. All authors read and approved the final manuscript.
###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
This work was supported by the Medical Research Council of Great Britain. The authors would like to thank Dr T Vyse for helpful discussions.
###end p 47
###begin article-title 48
###xml 10 15 <span type="species:ncbi:9606">human</span>
Update on human systemic lupus erythematosus genetics
###end article-title 48
###begin article-title 49
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Lupus susceptibility loci in New Zealand mice
###end article-title 49
###begin article-title 50
Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families
###end article-title 50
###begin article-title 51
Rapid secretion of interleukin-1beta by microvesicle shedding
###end article-title 51
###begin article-title 52
Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response
###end article-title 52
###begin article-title 53
Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis
###end article-title 53
###begin article-title 54
A blast from the past: clearance of apoptotic cells regulates immune responses
###end article-title 54
###begin article-title 55
The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus
###end article-title 55
###begin article-title 56
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor
###end article-title 56
###begin article-title 57
A cell-surface molecule involved in organ-specific homing of lymphocytes
###end article-title 57
###begin article-title 58
Metalloproteinase-mediated regulation of L-selectin levels on leucocytes
###end article-title 58
###begin article-title 59
###xml 77 82 <span type="species:ncbi:9606">human</span>
Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes
###end article-title 59
###begin article-title 60
Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases
###end article-title 60
###begin article-title 61
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases
###end article-title 61
###begin article-title 62
Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus
###end article-title 62
###begin article-title 63
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
###end article-title 63
###begin article-title 64
Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program
###end article-title 64
###begin article-title 65
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 40 45 <span type="species:ncbi:9606">human</span>
P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+stem and progenitor cells
###end article-title 65
###begin article-title 66
Subcellular localization of intracellular protein tyrosine phosphatases in T cells
###end article-title 66
###begin article-title 67
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice
###end article-title 67
###begin article-title 68
Caspase-independent cell death in T lymphocytes
###end article-title 68
###begin article-title 69
###xml 79 84 <span type="species:ncbi:9606">human</span>
An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor
###end article-title 69
###begin article-title 70
###xml 89 94 <span type="species:ncbi:9606">human</span>
An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor
###end article-title 70
###begin article-title 71
###xml 112 117 <span type="species:ncbi:9606">human</span>
P2X7 receptor polymorphism impairs extracellular adenosine 5' -triphosphate-induced interleukin-18 release from human monocytes
###end article-title 71
###begin title 72
Figures and Tables
###end title 72
###begin p 73
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 68 69 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 187 189 187 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 304 306 304 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 386 394 386 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CYCHROME</sup>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">PE </sup>
###xml 419 422 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">APC</sup>
###xml 475 479 475 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC</sup>
###xml 599 601 599 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 615 616 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 713 717 713 717 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 843 847 843 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC</sup>
###xml 849 853 849 853 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
P2X7-stimulated phosphatidylserine (PS) exposure on lymphocytes. P2X7-dependent exposure of PS on New Zealand Black (NZB) lymphocytes, New Zealand White (NZW) lymphocytes and (NZB x NZW)F1 (NZB/W) lymphocytes. To enable the direct comparison of responses of cells from NZB mice, NZW mice and (NZB x NZW)F1 mice in a single tube, lymphocytes from these strains were stained with anti-CD4CYCHROME, anti-CD4PE and anti-CD4APC, respectively, mixed and equilibrated with annexin VFITC. Thus labelled, cells could subsequently be distinguished by flow cytometric gating. Cells were stimulated with the P2X7 agonist 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP) at the time indicated by the arrow in (a). (a) Density plots of the rate of extracellular PS exposure in each cell population, as indicated by increased binding of annexin VFITC. (b) Corresponding percentage of cells bearing exposed PS in each population at a single timepoint (indicated by boxes in (a)).
###end p 73
###begin p 74
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 184 186 184 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 274 276 274 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">PE</sup>
###xml 286 295 286 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CYCHROME </sup>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">APC</sup>
###xml 359 363 359 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC</sup>
###xml 483 485 483 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 499 500 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 597 601 597 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 717 721 717 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC</sup>
###xml 723 727 723 727 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 866 868 866 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 936 938 936 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 990 994 990 994 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 1114 1123 1114 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CYCHROME </sup>
###xml 1137 1139 1137 1139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">PE</sup>
###xml 1401 1403 1400 1402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">PE</sup>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
P2X7-stimulated shedding of CD62L by lymphocytes. To enable the direct comparison of responses of cells from New Zealand Black (NZB) mice, New Zealand White (NZW) mice and (NZB x NZW)F1 (NZB/W) mice in a single tube, lymphocytes from these strains were stained with anti-CD4PE, anti-CD4CYCHROME and anti-CD4APC, respectively, mixed and stained with anti-CD62LFITC. Thus labelled, cells could subsequently be distinguished by flow cytometric gating. Cells were stimulated with the P2X7 agonist 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP) at the time indicated by the arrow in (a). (a) Density plots of the rate of CD62L shedding in each cell population, as indicated by decreased binding of anti-CD62LFITC. (b) Corresponding levels of cell surface CD62L in each population (NZB, red line; NZW, green line; NZB/W, black line) immediately preceding P2X7 stimulation (indicated by left-hand gates in (a)) or 7 min after P2X7 stimulation (indicated by right-hand gates in (a)). (c) Effect of a broad inhibitor of metalloproteinases on loss of CD62L. Lymphocytes from NZW mice were stained with anti-CD4CYCHROME and anti-CD62LPE, and the rate of loss of CD62L was assessed by flow cytometry. Cells were stimulated with BzATP in the presence or absence of 10 muM metalloproteinase inhibitor at the time indicated by an arrow. Shedding of CD62L is indicated by decreased binding of anti-CD62LPE. MMP, matrix metallopoteinase.
###end p 74
###begin p 75
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 63 72 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 132 133 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
P2X7-stimulated secretion of IL-1beta. Splenocytes were primed in vitro with lipopolysaccharide and were then stimulated with 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP) as indicated. The graph shows IL-1beta secretion by cells from New Zealand Black mice (open squares) and New Zealand White mice (filled squares). Each line represents IL-1beta secretion by cells from a single mouse.
###end p 75
###begin p 76
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 148 150 148 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 189 193 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">APC </sup>
###xml 205 209 205 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">FITC</sup>
###xml 318 320 316 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 398 400 396 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 467 469 465 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7 </sub>
###xml 489 490 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 537 541 535 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 544 546 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 557 561 555 559 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 564 566 562 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
P2X7-stimulated lymphocyte programmed cell death (PCD). Lymphocytes from New Zealand Black (NZB) mice, New Zealand White (NZW) mice and (NZB x NZW)F1 (NZB/W) mice were stained with anti-CD4APC and anti-CD8FITC, and were equilibrated with propidium iodide (PI). Panels show the mean percentage (+/- standard deviation, n = 5) of dead cells (those taking up PI) as assessed by flow cytometry before (t = 0), and at 15-min intervals subsequent to, stimulation of the P2X7 receptor with 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate. (a) CD4+ cells, and (b) CD8+ cells. NZB, open squares; NZW, open circles; NZB/W, open diamonds.
###end p 76

